MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS— 510(k) K013662

Substantially Equivalent

Quantimetrix Corp.

FDA 510(k) clearance K013662 for MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS, Substantially Equivalent on 2002-03-08. Applicant: Quantimetrix Corp..

Clearance details

Applicant: Quantimetrix Corp.
Product code: Code JHO
Advisory panel: Clinical Chemistry
Date received: 2001-11-06
Decision date: 2002-03-08
Decision: Substantially Equivalent
Clearance type: Special
Location: Redondo Beach, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.